drugset / Trial / NCT06132841
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
RandomizedSequentialSingle-blindTreatment
Summary
A study in healthy male and female participants of non-childbearing and childbearing potential who have overweight or obesity
Timeline
- Start
- 2023-11-13
- Primary completion
- 2026-02-03
- Completion
- 2026-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD6234 | Small activating RNA (saRNA) | — | Subcutaneous |
Indications
No indication recorded.